FINAL REFUSAL - MAILED
mailed
on 20 Nov 2024
Last Applicant/ Owned by
CH-8952 Schlieren
CH
Serial Number
79386345 filed on 04th Aug 2023
Registration Number
N/A
Correspondent Address
Alexander Montgomery
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
DINAQOR
Development and programming of computer software and software platforms for others for use in medical, biomedical, veterinary and pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for use in medical, biomedical, veterinary and pharmaceutical research and development; Stem cell research services; Consulting services relating to medical, biom Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Providing medical information in the field of medical care as it relates to the preparation and dispensing medications, in particular for cardiomyopathy, heart failure and kidney diseases; Providing medical information and consulting services in the field of medical care as it relates to medical, biomedical, veterinary and pharmaceutical products; Genetic screening for medical, biomedical, veterinary and pharmaceutical purposes; Human heart and kidney tissue bank services; medical services relating to the removal, treatment and processing of stem cells
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Development and programming of computer software and software platforms for others for use in medical, biomedical, veterinary and pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for use in medical, biomedical, veterinary and pharmaceutical research and development; Stem cell research services; Consulting services relating to medical, biomedical, veterinary and pharmaceutical research and development; research relating to medical, biomedical, veterinary and pharmaceutical research and development; Providing information about medical, biomedical, veterinary and pharmaceutical scientific research and development; Biological research and analysis, namely, analysis of human tissue for medical, biomedical, veterinary and pharmaceutical research purposes; design and development of medical diagnostic apparatus; Scientific research and development with respect to the isolation and cultivation of human cells and tissues; Programming of computer software for others for information platforms on the Internet for use in medical, biomedical, veterinary and pharmaceutical research and development; Rental of laboratory apparatus and instruments for scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection and teaching purposes for use in medical, biomedical, veterinary and pharmaceutical research and development; Rental and provision for other purposes of computer hardware and data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and development
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [035]
Advertising, Business & Retail Services
Advertising services; Commercial business administration, organization consulting, and management; Providing office functions; Business management consultancy; Company communication services, namely, public relations and providing business information for potential investors; Consulting services relating to personnel management; Personnel management; providing commercial information in the field of life science, health technology and medical technology; Providing marketing information; drawing up of statements of accounts; Retail store and wholesale store services featuring chemical and medical products and preparations, medical instruments and apparatus, and software in the medical field
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Medical apparatus and instruments for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Surgical apparatus and instruments; Paramedical apparatus and instruments, namely, apparatus and instruments for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Veterinary apparatus and instruments, namely, apparatus and instruments for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Medical instruments for the fusion of medicines, namely, syringes, infusion pumps, syringe systems, intravenous mixing sets, medical mixers, vial mixers, nebulizers, autoinjectors, balloon catheters; Apparatus for the regeneration of stem cells for medical purposes; Diagnostic apparatus for medical purposes, namely, for medical diagnostic testing related to heart and kidney diseases; Infusion sets; Artificial biomaterials for the argumentation of cardiac and kidney tissue for medical purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Recorded and downloadable computer software and platforms for the development of gene therapies; recorded and downloadable computer software and computer software platforms for use in medical, biomedical, veterinary and pharmaceutical research and development; scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, measuring, signaling, detection, testing, inspection, and teaching apparatus and instruments in the nature of high speed cameras, electric sensors and electric actuators, optical 2D scanners, optical filters, and photomultiplier tubes for use in medical, biomedical, veterinary and pharmaceutical research and development; weighing apparatus and instruments for use in medical, biomedical, veterinary and pharmaceutical research and development; Data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and development
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; medicinal and biomedical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; Biological tissue cultures for medical use; Biological solid organ tissue intended for subsequent implantation; Surgical implants made of living tissue; Biochemical preparations for medical use for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases and cancer; Stem cells for medical use; pharmaceutical, medical, biomedical and veterinary preparations, in particular for the treatment of heart diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Active chemical ingredients used in the manufacture of medicines for heart and kidney diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79386345
Mark Type
No Service Mark
Attorney Docket Number
No 080992-01980
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Nov 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 20th Nov 2024 | FINAL REFUSAL E-MAILED |
| 20th Nov 2024 | FINAL REFUSAL WRITTEN |
| 23rd Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 23rd Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 23rd Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 22nd May 2024 | REFUSAL PROCESSED BY IB |
| 27th Apr 2024 | REFUSAL PROCESSED BY MPU |
| 27th Apr 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 10th Apr 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |